Report Search Results	As of 9-Feb-2010
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 38) Release Date  Contributor Author Title Pages Price StarMine Author Rating More Info EPS Accuracy * Portfolio Return ** 9-Feb-10 New Constructs, LLC N/A VRX: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10     View Abstract 8-Feb-10 Market Edge N/A Market Edge Equity Research Report 4 $10     View Abstract 7-Feb-10 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (Global) 144 $169     View Abstract 7-Feb-10 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (North America) 100 $169     View Abstract 7-Feb-10 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (United States) 98 $169     View Abstract 7-Feb-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: VALEANT PHARMACEUTICALS INTL 5 $25     View Abstract 5-Feb-10 Reuters Investment Profile N/A Valeant Pharmaceuticals International: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20     View Abstract 5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: VALEANT PHARM -- VRX 1 $4     View Abstract 5-Feb-10 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of VALEANT PHARMACEUTICALS INTL including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 11 $20     View Abstract 5-Feb-10 Ford Investor Services, Inc. N/A Industry Value Graph: CEPH , KVA , MRX , PRGO , VRX -- DRUGS 3 $4     View Abstract Next 20

Brokerage Reports (Showing 1 to 3 of 3) Release Date  Contributor Author Title Pages Price StarMine Author Rating More Info EPS Accuracy * Portfolio Return ** 12-Jan-10 Thomson StreetEvents N/A VRX - Event Transcript of Valeant Pharmaceuticals International conference call, Jan. 11, 2010 / 8:30am ET 6 $75     View Abstract 8-Jan-10 Thomson StreetEvents N/A VRX - Event Transcript of Valeant Pharmaceuticals International conference call, Jan. 08, 2010 / 9:00am ET 16 $75     View Abstract 8-Jan-10 Thomson StreetEvents N/A VRX - Event Brief of Valeant Pharmaceuticals International conference call, Jan. 08, 2010 / 9:00am ET 17 $75     View Abstract

Independent Reports (Showing 1 to 10 of 35) Release Date  Contributor Author Title Pages Price More Info 9-Feb-10 New Constructs, LLC N/A VRX: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract 8-Feb-10 Market Edge N/A Market Edge Equity Research Report 4 $10 View Abstract 7-Feb-10 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (Global) 144 $169 View Abstract 7-Feb-10 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (North America) 100 $169 View Abstract 7-Feb-10 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (United States) 98 $169 View Abstract 7-Feb-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: VALEANT PHARMACEUTICALS INTL 5 $25 View Abstract 5-Feb-10 Reuters Investment Profile N/A Valeant Pharmaceuticals International: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract 5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: VALEANT PHARM -- VRX 1 $4 View Abstract 5-Feb-10 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of VALEANT PHARMACEUTICALS INTL including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 11 $20 View Abstract 5-Feb-10 Ford Investor Services, Inc. N/A Industry Value Graph: CEPH , KVA , MRX , PRGO , VRX -- DRUGS 3 $4 View Abstract Next 20